#Japan #Kagoshima #AMI Corporation #DNP-HF #Digital Biomarker

AMI Corporation and Its Groundbreaking Achievement

AMI Corporation, based in Kagoshima and Minamata City, has made a significant breakthrough in healthcare technology. On September 25, 2025, they successfully obtained regulatory approval for their digital biomarker program, known as DNP-HF, specifically designed for universal phonocardiography. This innovative product aims to transform the healthcare landscape by leveraging advanced technology and developing remote medical services.

Overview of the Approved Digital Biomarker

The DNP-HF is classified as a management medical device and corresponds to the generic name of a universal phonocardiography program. Its primary function is to analyze data from phonocardiograms and electrocardiograms provided by universal phonocardiographs. By estimating plasma BNP levels—whether they are above or below 100 pg/mL—the device aids in diagnostics by recording and displaying analyzed information. However, it is crucial to clarify that this tool does not serve as a definitive diagnostic tool for heart failure based solely on its analysis results.

AMI's commitment to healthcare innovation emphasizes creating a world where quality medical care is accessible to everyone, anywhere, without invasiveness and within a short timeframe. The startup is continuously accelerating its research and development in medical devices and associated services to realize this vision fully.

The Vision Behind AMI Corporation

Established in November 2015 and led by CEO Shinpei Ogawa, AMI Corporation is a research and development-driven startup rooted in Kyushu. With a focus on the “Digital Stethoscope” concept—equipped with heart disease diagnosis assist functions—the company aims to redefine the listening experience in healthcare. Their mission is not merely to digitize auscultation but to inject new value into the medical field through various applications such as clinical research, medical education, and telemedicine.

AMI Corporation utilizes a blend of acoustic engineering, electronic engineering, and AI technology in its product development, aiming for a future where high-quality medical services are available from any location.

Promotion and Outreach

To share their innovative approach and technologies, AMI Corporation has released a promotional video showcasing the DNP-HF and its applications, which can be found here. This video serves as a valuable resource for medical professionals who are interested in the latest advancements in telemedicine and remote healthcare solutions.

Though aimed at healthcare personnel, the promotional material reflects AMI's dedication to enhancing medical standards and pushing the boundaries of healthcare delivery.

Company Summary

• - Company Name: AMI Corporation
• - CEO: Shinpei Ogawa
• - Established: November 2015
• - Website: AMI Corporation
• - Headquarters: 2-13 Higashisenmatsu, Kagoshima City, Kagoshima Prefecture, 302
• - Main Office: 5-98 Hamamatsu-cho, Minamata City, Kumamoto Prefecture
• - Business Scope: Development of medical devices and telemedicine service provision

It’s important to note that this press release is intended for stakeholders, including reporters, shareholders, and investors, and is not targeted at the general public for providing medical information or attracting customers.